Globus Medical (GMED) return on equity (ROE)

Return on equity · fiscal 2025
11.8%

Globus Medical (GMED) earned a return on equity of 11.8% in fiscal 2025 (the year ended December 31, 2025). That is 9.3 percentage points higher than the 2.5% of fiscal 2024. Figures as of 18 Nov 2026, 01:29 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
11.8%
Change on fiscal 2024
+9.3 pts
Highest on record
23.9%fiscal 2010
Lowest on record
2.5%fiscal 2024
Fiscal years on record
162010–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Globus Medical return on equity (ROE), in more detail

Across the 16 fiscal years on record (2010–2025), the highest was 23.9% in fiscal 2010 and the lowest 2.5% in fiscal 2024. The fiscal 2025 figure is higher than in 47% of the 15 earlier fiscal years on record, whose median is 12.5%.

History · 16 fiscal years

Return on equity by fiscal year

Globus Medical return on equity (ROE), year by year

Globus Medical (GMED) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
202511.8% 9.3 pts up
20242.5% 0.6 pts down
20233.1% 7.2 pts down
202210.3% 1.7 pts up
20218.6% 1.8 pts up
20206.8% 4.3 pts down
201911.1% 2.1 pts down
201813.2% 2.1 pts up
201711.1% 1.4 pts down
201612.5% 3.2 pts down
201515.8% 0.0 pts
201415.8% 1.3 pts up
201314.5% 4.6 pts down
201219.1% 2.4 pts down
201121.5% 2.3 pts down
201023.9%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of Globus Medical and comparable companies
CompanyReturn on equityFiscal year
Spyre Therapeutics SYRE-21.7%2025
Qiagen QGEN11.2%2025
Insulet PODD16.3%2025
Bruker BRKR-0.3%2025
Globus Medical GMED11.8%2025
Madrigal Pharmaceuticals MDGL-47.8%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on GMED

Globus Medical, figure by figure

Globus Medical (GMED) overview: price, valuation and scorecardAll health care companies by market value

Globus Medical return on equity (ROE): questions and answers

What is Globus Medical's return on equity?

Globus Medical (GMED) earned a return on equity of 11.8% in fiscal 2025 (the year ended December 31, 2025). That is 9.3 percentage points higher than the 2.5% of fiscal 2024.

Is Globus Medical's return on equity high or low compared with its own history?

The fiscal 2025 figure is higher than in 47% of the 15 earlier fiscal years on record, whose median is 12.5%.

What are the highest and lowest return on equity figures on record for Globus Medical?

Across the 16 fiscal years on record (2010–2025), the highest was 23.9% in fiscal 2010 and the lowest 2.5% in fiscal 2024.

How is Globus Medical's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Globus Medical (GMED) return on equity (ROE)”, data as of 18 November 2026. https://funkfolio.com/stock/GMED/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.